A case study of Reorganisation - Essay Example

Since there are now a large number of companies with suitable capacity, or availability of funds due to investment interest from the general public, there is now a lot of competition and a continuous pressure to develop new drugs. As a result, some companies have come out on top with Glaxo Smith Kline, Astra Zeneca, Pfizer, Shire Pharmaceuticals, Eli Lilly, Merial, Roche, Merck Sharp and Dohme and Novartis being the top companies. (Great Britain Parliament, House of Commons, Health Committee, 215) Do the companies look that they are in trouble?

At the same time, the government requires medicines for support of some activities that it has been doing for a long time and they are curtailed for some time since a decision has been taken that there should be no loss incurred by government help to the needy. Is it justified, or is it impossible for the government to force these companies to help the needy public with a supply of essential medicines? Whereas the motor vehicle sector of the industry in the UK has fallen behind other countries in Europe as technological capabilities have dropped.

The plants for the manufacture of motor vehicles in Britain have been joined to the existing chains in Europe for the different multinational companies and this has reduced the amount of research that is going on in the UK. On the other hand, the pharmaceutical sector has been chosen by the multinational enterprises for improvement of research facilities and thus it now occupies an important position on the continent.. es have come out on top with Glaxo Smith Kline, Astra Zeneca, Pfizer, Shire Pharmaceuticals, Eli Lilly, Merial, Roche, Merck Sharp and Dohme and Novertis being the top companies.

(Great Britain Parliament, House of Commons, Health Committee, 215) Do the companies look that they are in trouble At the same time, the government requires medicines for support of some activities that it has been doing for a long time and they are curtailed for some time since a decision has been taken that there should be no loss incurred by government help to the needy. Is it justified, or is it impossible for the government to force these companies to help the needy public with supply of essential medicines Whereas the motor vehicle sector of the industry in UK has fallen behind other countries in Europe as technological capabilities have dropped.

The plants for manufacture of motor vehicles in Britain have been joined to the existing chains in Europe for the different multinational companies and this has reduced the amount of research that is going on in UK. On the other hand, the pharmaceutical sector has been chosen by the multinational enterprises for improvement of research facilities and thus it now occupies and important position on the continent. The country is now the home to 4 of the 32 of the largest producers of medicines in the world.

It is not that this arrangement is harmful for the companies which have set up facilities for research in Britain. They get the advantage of the training in science that the students here get. (Ross, 183) At the same time, it is also clear that the benefits that the companies get do not depend on the training or education that students get. (Mark, 88) Thus it is clear that industry is trying to get the full benefit that Britain has to offer